loading

Beam Therapeutics Inc Azioni (BEAM) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
1,077%
114.11
9.698 8.466 7.47 30.07
Operating Expenses
3.63%
131.55
136.51 128.62 126.76 130.10
Benefits Costs and Expenses
206.34%
-130.19
122.43 110.76 116.74 120.42
Costs And Expenses
206.34%
-130.19
122.43 110.76 116.74 120.42
Depreciation and Amortization
1.94%
5.668
5.56 5.538 5.528 -
Operating Income/Loss
86.24%
-17.45
-126.81 -120.15 -119.29 -100.04
Nonoperating Income/Loss
1,759%
261.74
14.08 17.86 10.02 9.683
Income/Loss From Continuing Operations Before Tax
316.71%
244.30
-112.73 -102.29 -109.27 -90.35
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
316.71%
244.30
-112.73 -102.29 -109.27 -90.35
Net Income/Loss
316.71%
244.30
-112.73 -102.29 -109.27 -90.35
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
98.70%
1.3383
102.57 102.00 87.98 0.1716
Diluted Average Shares
98.70%
1.3383
102.57 102.00 87.98 0.1716
Basic Earnings Per Share
328.18%
2.51
-1.10 -1.00 -1.24 -1.09
Diluted Earnings Per Share
328.18%
2.51
-1.10 -1.00 -1.24 -1.09
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):